Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ninan T Mathew

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Headache|September 18, 2007
The use of questions to determine the presence of photophobia and phonophobia during migraineRandolph W Evans, Tad Seifert, Jayasree Kailasam, et al.
Headache|June 14, 2008
Rational combination therapy in refractory migraineB Lee Peterlin, Anne H Calhoun, Sherry Siegel, et al.
Headache|October 23, 2002
Intractable cluster headaches in a migraineurJohn F Rothrock, Ninan T Mathew, Alex O Kaup, et al.
Headache|February 27, 2003
Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mgNinan T Mathew, Jean Schoenen, Paul Winner, et al.
Headache|April 20, 2005
Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trialNinan T Mathew, Benjamin M Frishberg, Marek Gawel, et al.
Cephalalgia : an International Journal of Headache|July 22, 2010
Quantifying the return of headache in triptan-treated migraineurs: an observational studyFred Sheftell, Mary Almas, Randall Weeks, et al.
Pain Medicine (Malden, Mass.)|August 25, 2007
A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraineJoel R Saper, Ninan T Mathew, Elizabeth W Loder, et al.
Archives of Neurology|June 18, 2002
Intranasal civamide for the treatment of episodic cluster headachesJoel R Saper, Jack Klapper, Ninan T Mathew, et al.
Headache|May 20, 2008
Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trialSteven L Linder, Ninan T Mathew, Roger K Cady, et al.
Headache|June 3, 2009
Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-lifeNinan T Mathew, Stephen Landy, Stuart Stark, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Headache|September 18, 2007
The use of questions to determine the presence of photophobia and phonophobia during migraineRandolph W Evans, Tad Seifert, Jayasree Kailasam, et al.
Headache|June 14, 2008
Rational combination therapy in refractory migraineB Lee Peterlin, Anne H Calhoun, Sherry Siegel, et al.
Headache|October 23, 2002
Intractable cluster headaches in a migraineurJohn F Rothrock, Ninan T Mathew, Alex O Kaup, et al.
Headache|February 27, 2003
Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mgNinan T Mathew, Jean Schoenen, Paul Winner, et al.
Headache|April 20, 2005
Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trialNinan T Mathew, Benjamin M Frishberg, Marek Gawel, et al.
Cephalalgia : an International Journal of Headache|July 22, 2010
Quantifying the return of headache in triptan-treated migraineurs: an observational studyFred Sheftell, Mary Almas, Randall Weeks, et al.
Pain Medicine (Malden, Mass.)|August 25, 2007
A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraineJoel R Saper, Ninan T Mathew, Elizabeth W Loder, et al.
Archives of Neurology|June 18, 2002
Intranasal civamide for the treatment of episodic cluster headachesJoel R Saper, Jack Klapper, Ninan T Mathew, et al.
Headache|May 20, 2008
Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trialSteven L Linder, Ninan T Mathew, Roger K Cady, et al.
Headache|June 3, 2009
Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-lifeNinan T Mathew, Stephen Landy, Stuart Stark, et al.
Pageof 4